• Iron Ore
• Close to China, Japan and Korea
• Significant potential reserves
• Low cost production

Consolidated Iron Sands
Zodiac Capital has a controlling interest in Consolidated Iron Sands Limited (CIS). CIS plans to list on the Australian Stock Exchange (ASX) in 2009. CIS owns key iron sands tenements over 16,300 hectares (163 square kilometres) within the shallow offshore regions of the northern Philippines coastline.  Extensive magnetite sand reserves were identified within the immediate region through studies spanning the period 1970-1990 by the Philippine Mines and Geosciences Bureau and by a United Nations Exploration Survey program.  A ban on offshore mining has recently been lifted, providing CIS the opportunity to contribute to the re-establishment of the Philippines as a strategic and significant supplier of iron ore on a world scale.  Following public listing CIS is planning initial iron ore magnetite fines production of 2 million tones per annum commencing in late 2010.

• Agricultural
• Grows organic food almost anywhere
• Year round production
• Fraction of water and land requirements
• Carbon Credit positive

Dynamic Agricultural Products Ltd.
Zodiac Capital owns a majority and controlling interest in Dynamic Agricultural Products Limited which plans to list on the Australian Stock Exchange (ASX) in the course of 2009. Dynamic is commercializing a patent pending vertical agricultural farming system, which incorporates proven technologies that address bio-security, water quality and availability, availability of arable land and the control of pests, mould and other bacterial problems that often threaten traditional and intensive production methods. The Dynamic system introduces vertical automated farming that can be sited in any location ranging from remote sites in developing countries to city warehouses.  The Dynamic system provides dramatic and cost-effective reduction in carbon emissions, water usage, spoilage losses, fertilizers, pesticides, refrigeration, land use and freight.  In summary, the Dynamic system can - naturally and organically - produce vegetables and other crops at up to seven times the growth rate of traditional methods.  Comparatively, each 10,000 square metre unit can replace up to 50,000 acres of traditional production land and use only 1000th of the water and no pesticides or herbicides.

• Phyto-pharmaceutical all natural
• Existing range of 26+ products
• Global rights
• Effective in treating significant conditions – TB, HIV, cholesterol, diabetes

Zocap Pharma
Zocap Pharma owns the global rights to 26 fully developed phyto-pharmaceutical products, including a number of potential blockbuster candidates that have been developed within Russian research institutes over the past 25 years and are currently only available through pharmacies in the Ukraine. The products have many of the attributes of true pharmaceuticals and are regulated in most countries under such categories as natural remedies, food supplements or traditional medicines.  Zocap has started operations that will lead to early marketing initiatives in selected regions and looks forward to achieving potentially significant revenues within its first full year of operations as these markets expand and the Zocap products are introduced to new regions.   The first Zocap Pharma product that the Company is focused on introducing to global markets is Immunoxel, a proven and very effective complementary agent in the treatment of tuberculosis (“TB”), a highly contagious condition and major scourge within mainly developing countries and a serious health threat to the western world.  Approximately a third of the world’s population now carries the TB bacteria.  Extensive clinical trials show that Immunoxel significantly enhances the effects of anti-TB and anti-TB/HIV drugs and protects the liver from drug related toxicity. Importantly, Immunoxel has demonstrated significant effectiveness against the rapidly emerging drug resistant strains of TB.  Other key Zocap products in clinical trials have demonstrated effectiveness in the reduction of cholesterol (Cholonorm) and blood sugar (Diabetin).